Israel Active

Israeli startup Motus GI has developed the FDA-approved Pure-Vu system, that allowing doctors to clean poorly prepped colons during a colonoscopy. It would make preparing for a colonoscopy much easier. Motus is preparing a NASDAQ launch to raise up to $28.8 million.

Israel’s Accurate Medical has developed a range of microcatheters for cutting off the blood supply (embolization) to tumors and vascular aneurysms. French medical imaging company Guerbet has just acquired Accurate for up to 57 million Euros.  Accurate will continue to operate from Israel.

I reported previously (Oct 2012) that Israeli bio-tech Metallo Therapy was using gold nanoparticles to improve radiotherapy treatment for cancer. Unfortunately, Metallo folded in 2016, but now a team of Israeli researchers are headed down the same precious “yellow-brick” road.

The Rapid Cancer Diagnostic Unit at Sheba Medical Center uses new diagnostic oncology technology developed by Dr. Damien Urban. It cuts patient waiting time from previously 3 months to just two weeks. Its goal is to help overcome the devastating delays in the diagnosis and treatment of cancer.

Israeli health fund Maccabi has launched K Health - an app to give its customers medical advice that many seek currently by using search engines such as Google. The information is sourced from thousands of similar cases in Maccabi’s records database. Currently in Hebrew and Israel only.

Israeli companies HeartBeat Technologies and Brainsway have been selected for a joint Israel-Canada partnership program. They will test their innovative aging and brain health solutions at two Canadian seniors care organizations.

ILTV News interviewed Shlomo Emanuel, CEO of Israel’s Dentalics which has developed an app to help dentists and dental technicians match up the color of implants, bridges, crowns etc. with the patient’s real teeth. It is planned to launch globally in Feb 2018.

Tel Aviv University researchers have discovered that 7% of pancreatic cancer sufferers survive more than five years due to high levels of the gene miR-34a and low levels of the gene PLK1. They then devised a nanoparticle to deliver miR-34a and a PLK1 silencer direct to the tumor.

I reported previously on Israel’s GlucoMe blood glucose monitors for diabetics.  Now, Apollo Sugar - the Indian national chain of 55 diabetes clinics – is to supply kits containing a GlucoMe monitor to each of its 200,000 diabetic patients.

A study of 26,702 Israeli expectant mothers and 45,300 children by a team led by Haifa University researchers, has revealed that mothers who take folic acid and multivitamin supplements before and during pregnancy are 73% less likely to have an autistic child.